pcn Q&As

Stuart McKinlay, BHSc, Sonya Grewal, BSc, and Bianca Wollenhaupt de Aguiar, BSc, MSc, Ph.D.

Q&As

Identifying the Biological Pathways Involved in Bipolar Disorder Progression, Part 2

04/10/2023

In part 2 of this Q&A, McKinlay, Grewal, and Wollenhaupt de Aguiar discuss what clinicians can take away from their results and where future research needs to go.

In part 2 of this Q&A, McKinlay,...

04/10/2023

Psych Congress Network

Q&As

Bipolar Disorder Progression Associated With Increase in Ventricular Size, Authors Say

04/10/2023

In Part 1 of this Q&A, the authors discuss the inspiration for the study, the most significant findings, and which outcomes were surprising.

In Part 1 of this Q&A, the...

04/10/2023

Psych Congress Network

Kristen P. Perrett, PhD, and Gillian M. Nixon, PhD.

Q&As

Prioritizing Practical Treatment Options for Pediatric Sleep-Disordered Breathing

03/13/2023

Specialty treatment is often called upon for pediatric sleep-disordered breathing, but there may be a more accessible option available through primary care. Neurology Learning Network spoke with Kristen P. Perrett, associate professor,...

Specialty treatment is often...

03/13/2023

Neurology

Q&As

Preventing, Recognizing, and Treating Tardive Dyskinesia in Patients Taking Antipsychotics

03/01/2023

What does prevention-based TD treatment look like with 2 FDA-approved medications as an option? What should clinicians do should TD develop in their patient? These answers and more.

What does prevention-based TD...

03/01/2023

Psych Congress Network

Q&As

Intranasal Spray an Effective First-Line Treatment for Pediatric Sleep-Disordered Breathing

02/27/2023

While the recommended treatment for pediatric sleep-disordered breathing is often a tonsillectomy, could there be a quicker, easier, and less painful first-line treatment administered in a primary care setting? Find out in this expert Q&A.

While the recommended treatment...

02/27/2023

Psych Congress Network

Drs Elisa Nelson, Christian Kohler, and Monica Calkins.

Q&As

Using Telehealth to Decrease Treatment Interference for First-Episode Psychosis Patients

02/22/2023

How successful is remote treatment for first-episode psychosis via telehealth? Learn more from Elisa Nelson, PhD, Monica Calkins, PhD, and Christian Kohler, PhD.

How successful is remote...

02/22/2023

Psych Congress Network

Q&As

Maintaining Continuity of Care for First-Episode Psychosis Through Telehealth

02/17/2023

For patients experiencing first-episode psychosis (FEP), specialty care in a dedicated setting is especially important to ensure consistent treatment engagement. How well does that specialty care translate to a telehealth setting?

For patients experiencing...

02/17/2023

Psych Congress Network

Q&As

Poor Sleep Linked With Future Cognitive Decline, Clinicians Should Target Intervention

02/07/2023

Dr Behrens provides much-needed insight as clinicians treat patients presenting symptoms of sleep disorders who may be at risk for future decline.

Dr Behrens provides much-needed...

02/07/2023

Neurology

Q&As

A Neuroscientific Approach to Bereavement and Prolonged Grief Disorder With Dr Mary-Frances O’Connor

12/15/2022

Mary-Frances Oconnor, PhD, on the brain's role in shaping the experience of bereavement and prolonged grief disorder.

Mary-Frances Oconnor, PhD, on...

12/15/2022

Psychiatry & Behavioral Health

Q&As

Anticipating Access Obstacles for Psychedelic-Assisted Therapies

10/17/2022

Rick Doblin, PhD, explains what clinicians should be thinking about in regards to accessibility for psychedelic therapies, when access should be limited, and common misconceptions that need to be cleared up.

Rick Doblin, PhD, explains what...

10/17/2022

Psych Congress Network

Q&As

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Sign Up

Specialties

Events

Year Round Education

HMP Global Products